Shopping Cart 0
Cart Subtotal
USD 0

Veracyte Inc (VCYT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750

Details

Summary

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company's pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte provides genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

Veracyte Inc (VCYT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Veracyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9

Veracyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Veracyte Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Veracyte Secures USD14.95 Million in Venture Funding 11

Partnerships 12

Veracyte Enters into Research Agreement with Loxo Oncology 12

Equity Offering 13

Veracyte Raises USD40 Million in Private Placement of Shares 13

Veracyte Completes IPO For USD 65 Million 15

Veracyte Inc-Key Competitors 16

Veracyte Inc-Key Employees 17

Veracyte Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

May 01, 2018: Veracyte Reports First Quarter 2018 Financial Results 19

Feb 27, 2018: Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results 20

Nov 06, 2017: Veracyte Announces Third Quarter 2017 Financial Results 22

Jul 31, 2017: Veracyte Announces Second Quarter 2017 Financial Results 24

May 03, 2017: Veracyte Announces First Quarter 2017 Financial Results 25

Mar 01, 2017: Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 26

Corporate Communications 27

Feb 28, 2017: Veracyte Announces Executive Promotions 27

Other Significant Developments 28

Jan 08, 2018: Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Veracyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Veracyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Veracyte Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Veracyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Veracyte Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9

Veracyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Veracyte Secures USD14.95 Million in Venture Funding 11

Veracyte Enters into Research Agreement with Loxo Oncology 12

Veracyte Raises USD40 Million in Private Placement of Shares 13

Veracyte Completes IPO For USD 65 Million 15

Veracyte Inc, Key Competitors 16

Veracyte Inc, Key Employees 17

Veracyte Inc, Other Locations 18

Veracyte Inc, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Veracyte Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company's pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte provides genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

Veracyte Inc (VCYT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Veracyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9

Veracyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Veracyte Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Veracyte Secures USD14.95 Million in Venture Funding 11

Partnerships 12

Veracyte Enters into Research Agreement with Loxo Oncology 12

Equity Offering 13

Veracyte Raises USD40 Million in Private Placement of Shares 13

Veracyte Completes IPO For USD 65 Million 15

Veracyte Inc-Key Competitors 16

Veracyte Inc-Key Employees 17

Veracyte Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

May 01, 2018: Veracyte Reports First Quarter 2018 Financial Results 19

Feb 27, 2018: Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results 20

Nov 06, 2017: Veracyte Announces Third Quarter 2017 Financial Results 22

Jul 31, 2017: Veracyte Announces Second Quarter 2017 Financial Results 24

May 03, 2017: Veracyte Announces First Quarter 2017 Financial Results 25

Mar 01, 2017: Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 26

Corporate Communications 27

Feb 28, 2017: Veracyte Announces Executive Promotions 27

Other Significant Developments 28

Jan 08, 2018: Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Veracyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Veracyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Veracyte Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Veracyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Veracyte Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9

Veracyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Veracyte Secures USD14.95 Million in Venture Funding 11

Veracyte Enters into Research Agreement with Loxo Oncology 12

Veracyte Raises USD40 Million in Private Placement of Shares 13

Veracyte Completes IPO For USD 65 Million 15

Veracyte Inc, Key Competitors 16

Veracyte Inc, Key Employees 17

Veracyte Inc, Other Locations 18

Veracyte Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Veracyte Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.